Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Behling

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Neuro-Oncology|December 23, 2024
VGLL fusions define a new class of intraparenchymal central nervous system schwannomaSimone Schmid, Kanish Mirchia, Anna Tietze, et al.
Nature Medicine|August 21, 2024
Molecular classification to refine surgical and radiotherapeutic decision-making in meningiomaJustin Z Wang, Vikas Patil, Alexander P Landry, et al.
Neuro-Oncology|April 18, 2025
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genesPhilipp Sievers, Sonali Arora, Thomas Hielscher, et al.
Acta Neuropathologica|June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytomaMaja Krech, Amos Muench, Daniel Teichmann, et al.
Neuro-Oncology|November 6, 2024
Validation and next-generation update of a DNA methylation-based recurrence predictor for meningioma: A multicenter prospective studyAlexander P Landry, Justin Z Wang, Vikas Patil, et al.
Nature Genetics|February 9, 2026
A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classificationSybren L N Maas, Yiheng Tang, Eric Stutheit-Zhao, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Neuro-Oncology|December 23, 2024
VGLL fusions define a new class of intraparenchymal central nervous system schwannomaSimone Schmid, Kanish Mirchia, Anna Tietze, et al.
Nature Medicine|August 21, 2024
Molecular classification to refine surgical and radiotherapeutic decision-making in meningiomaJustin Z Wang, Vikas Patil, Alexander P Landry, et al.
Neuro-Oncology|April 18, 2025
Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genesPhilipp Sievers, Sonali Arora, Thomas Hielscher, et al.
Acta Neuropathologica|June 11, 2025
Outcome-associated factors in a molecularly defined cohort of central neurocytomaMaja Krech, Amos Muench, Daniel Teichmann, et al.
Neuro-Oncology|November 6, 2024
Validation and next-generation update of a DNA methylation-based recurrence predictor for meningioma: A multicenter prospective studyAlexander P Landry, Justin Z Wang, Vikas Patil, et al.
Nature Genetics|February 9, 2026
A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classificationSybren L N Maas, Yiheng Tang, Eric Stutheit-Zhao, et al.
Pageof 8